Inhalation of nitric oxide
AssigneeBeyond Air, Inc.
InventorsAmir Avniel, Ali Ardakani, Steven A. Lisi
Life of this patent
Estimating the term…
Loading patent…
AssigneeBeyond Air, Inc.
InventorsAmir Avniel, Ali Ardakani, Steven A. Lisi
Estimating the term…
A method of treating a human subject which is effected by inhalation of gaseous nitric oxide over a period of 8 day to about 28 days is disclosed. The method can be utilized for treating a human subject suffering from, or prone to suffer from, a disease or disorder that is manifested in the respiratory tract, or from a disease or disorder that can be treated via the respiratory tract. The disclosed method can be effected while monitoring one or more of on-site and off-site parameters such as vital signs, methemoglobin levels, pulmonary function parameters, blood chemistry and hematological parameters, blood coagulation parameters, inflammatory marker levels, liver and kidney function parameters and vascular endothelial activation parameters, such that no substantial deviation from a baseline in seen in one or more of the monitored parameters.
A method of delivering gaseous nitric oxide (gNO) to a patient in need thereof, the method comprising the step of administering at least 3200 ppm-hrs to about 12,000 ppm-hrs of gNO by inhalation over a period from at least 8 to about 28 days.
Dependencies are inferred from the claim text.